|
Graves Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Autoimmune thyroid disease (AITD) occurs in two common forms: Graves' disease and Hashimoto thyroiditis.
|
12914522 |
2003 |
|
Graves Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
CD40 rs1883832 is associated with decreased risk of Graves' disease, especially in Asian; CD40 rs1883832 is associated with increased risk of multiple sclerosis; CD40 -1C>T (rs1883832) is not associated with the susceptibility of Hashimoto's thyroiditis, systemic sclerosis or Asthma; there is insufficient data to fully confirm the association between CD40 rs1883832 and systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), Behçet's disease (BD), myasthenia gravis (MG), Crohn's disease (CD), ulcerative colitis (UC), Sarcoidosis, Fuch uveitis syndrome (FUS), Vogt-Koyanagi-Harada syndrome (VKH), Kawasaki disease (KD), giant cell arteritis (GCA) or Immune thrombocytopenia (ITP).
|
29254239 |
2017 |
|
Graves Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
We describe a rare case of a biopsy-proven PM in a euthyroid patient, without history of GD or Hashimoto's thyroiditis.
|
29858862 |
2018 |
|
Graves Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
The various identified diseases were: celiac disease (n=1), psoriasis (n=1), Hashimoto thyroiditis (n=1), Graves disease (n=1), optic neuritis (n=2), skin hypopigmented lesions/vitiligo (n=2), allergic rhinitis/asthma (n=1), and neuropathy responding to glucocorticoid treatment (n=1).
|
29458220 |
2018 |
|
Graves Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Hashimoto's thyroiditis and Graves' disease) and type 1 diabetes mellitus are the most common autoimmune endocrine disorders associated with DS, and present with some peculiar features.
|
28245458 |
2017 |
|
Graves Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Two patients (3.3%) showed autoimmune thyroid diseases, 1 each with Graves' disease and Hashimoto thyroiditis.
|
15995343 |
2005 |
|
Graves Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Associated thyroid diseases could be observed in the remaining lobe in all patients and included hyperthyroidism, hypothyroidism, nodular goiter, toxic goiter, hypofunctioning nodules, Graves' disease and Hashimoto-thyroiditis.
|
30974469 |
2019 |
|
Graves Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Among the AITD patients, the adjusted HR for CSU was higher in patients with Hashimoto's thyroiditis (HR, 1.50) than in those with Grave's disease (HR, 1.33), although the difference was not statistically significant (P=0.368).
|
28497925 |
2017 |
|
Graves Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Methods The study groups consisted of 44 children with Graves' disease (GD), 65 children with Hashimoto's thyroiditis (HT), 199 children with T1DM with or without AITDs and 58 control children.
|
30903759 |
2019 |
|
Graves Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
The autoimmune thyroid diseases (AITDs) include two related disorders, Graves disease (GD) and Hashimoto thyroiditis, in which perturbations of immune regulation result in an immune attack on the thyroid gland.
|
9837828 |
1998 |
|
Graves Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
The group comprised 45 newly diagnosed children with Hashimoto's thyroiditis and Graves' disease versus euthyroid control group: 11 with hypothyroidism (10 girls and 1 boy, aged 12.2 ± 1.9 years), 19 children with hyperthyroidism (15 girls and 4 boys, aged 12.4 ± 4.9 years) and 15 healthy subjects (7 girls and 8 boys, aged 10.5 ± 4.8 years).
|
28276714 |
2017 |
|
Graves Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
A total of 136 participants were recruited, including Graves' disease (GD) (n = 36), Hashimoto's thyroiditis (HT) (n = 33) and thyroid autoantibody-positive (pTAb) (n = 29) patients and 38 age- and sex-matched healthy controls (HCs).
|
30725486 |
2019 |
|
Graves Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
In this context, it is of relevance the strong association of vitiligo with other autoimmune diseases, in particular with autoimmune thyroid disorders, such as Hashimoto thyroiditis and Graves' disease.
|
29163360 |
2017 |
|
Graves Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Studies in cells and tissues of patients with autoimmune thyroid diseases (AITD), and particularly in Graves' disease (GD) and Hashimoto's thyroiditis (HT), are increasingly revealing altered epigenetic marks and resultant deregulation of gene expression levels, but the available data are still limited to be translated into the clinical settings.
|
28706507 |
2017 |
|
Graves Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Patients with autoimmune thyroid diseases (ATD) such as Graves' disease (GD) and Hashimoto thyroiditis (HT) may have non-organ specific autoantibodies such as antinuclear antibodies (ANA) and rheumatoid factor (RF).
|
29864750 |
2018 |
|
Graves Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Patients with Hashimoto's Thyroiditis (HT) or Graves' Disease (GD) were individually compared to a control group of patients with early stage malignancy or goiter.
|
31651072 |
2020 |
|
Graves Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
The different actions of the anti-thyroid antibodies correspond to differences in cellular location of the antigens, titers of the circulating antibodies, duration of antibody exposure, and immunological mechanisms in GD and Hashimoto's thyroiditis.
|
28536577 |
2017 |
|
Graves Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Totally, 319 patients with Graves' disease (GD), 83 patients with Hashimoto's thyroiditis (HT) and 351 healthy controls were recruited.
|
31494956 |
2019 |
|
Graves Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Thyroglobulin (TG) is a major susceptibility gene for both Graves disease and Hashimoto thyroiditis.
|
30113675 |
2018 |
|
Graves Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The autoimmune thyroid diseases (AITDs), comprising Graves disease (GD) and Hashimoto thyroiditis (HT), develop as a result of a complex interaction between predisposing genes and environmental triggers.
|
12973666 |
2003 |
|
Graves Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Ten samples from TBAb-positive/TSAb-negative patients with GD or Hashimoto's thyroiditis were positive in all binding assays.
|
29071236 |
2017 |
|
Graves Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
However, several studies have suggested that thyroid cancer coexists with autoimmune thyroid diseases like Hashimoto Thyroiditis (HT) and Graves disease (GD).
|
30616690 |
2019 |
|
Graves Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
A greater prevalence of Graves' disease (0.94% vs. 0.46%, P < 0.001), Hashimoto's thyroiditis (2.68% vs. 0.80%, P < 0.001), and thyroid cancer (1.81% vs. 1.30%, P < 0.001) was observed in SLE patients than in control subjects.
|
28654679 |
2017 |
|
Graves Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Families from the Lupus Multiplex Registry and Repository were studied in which there was at least 1 member who had both SLE and AITD (Graves' disease or Hashimoto thyroiditis).
|
16255059 |
2005 |
|
Graves Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Superb Microvascular Imaging in the Evaluation of Pediatric Graves Disease and Hashimoto Thyroiditis.
|
31705696 |
2019 |